Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Japanese lab prepares new, broad-spectrum carbapenems

Dec. 7, 1998

Potent antifungal triazoles reported by Sankyo

Dec. 7, 1998

Potent anti-MRSA agents developed by Sankyo

Dec. 4, 1998

Ascent to terminate copromotion agreement with Bristol-Myers Squibb

Dec. 4, 1998

Ascent to promote Warner-Lambert's Omnicef

Dec. 3, 1998

Bausch & Lomb to manufacture Lidakol for treatment of oral-facial herpes

Dec. 3, 1998

AMBI seeks partners to develop injectable nisin for treatment of hospital-acquired infections

Dec. 3, 1998

Pfizer announces further product launches for novel quinolone

Dec. 2, 1998

FDA approves new indications, dosing regimens for Vantin

Dec. 2, 1998

Improved antibacterial efficacy observed with OPC-20011

Dec. 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...